Stericycle Q3 Profit Misses By $0.11

Stericycle (SRCL – Get Report) stock is diving by 20.22% to $118.91 in late afternoon trading on Friday, after the company reported financial results for the 2015 third quarter that were short of analysts’ estimates on Thursday. Moreover, Capital Investment Services Of America Inc. has 3% invested in the company for 98,120 shares. Finally, Robert W. Baird downgraded the stock to “Neutral” rating in an October 23 report.

The average recommendation is the arithmetical average of the individual analyst ratings contributed by sell-side research to produce a Consensus Analyst Rating for each stock.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, October 22nd. “Year-to-Date the stock performance stands at 13.6%”. Analysts polled by Thomson Reuters expected the company to report profit per share of $1.19 for the quarter. In a research note issued to the investors, the brokerage major Lowers a price-target of $130.00 per share. The shares closed down 1.02 points or 0.68% at $148.91 with 717,239 shares getting traded. Stericycle has a 1-year low of $110.56 and a 1-year high of $151.57. Equities research analysts predict that Stericycle Inc will post $4.67 earnings per share for the current fiscal year. William Blair reissued a “buy” rating on shares of Stericycle in a research report on Friday, October 9th. The firm has a market cap of $10.21 billion and a price-to-earnings ratio of 34.47.

GAAP earnings per diluted share decreased 51.6% to $0.47 from $0.96 in the third quarter past year. Gross profit, adjusted for various items, was reported to be $886.8 million, increasing 9.2% YoY.

In other news, Director Rodney F. Dammeyer sold 8,500 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The firm has a 50-day moving average price of $142.10 and a 200-day moving average price of $139.00. The rating is an average of the various different ratings given by analysts and brokers to Stericycle Incorporated, and then averaged into one rating by a team of analysts at Zacks in Chicago, Illinois. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Stericycle, Inc.is engaged in the business of providing regulated and compliance solutions to healthcare and commercial businesses. The Company is the second-largest provider of regulated medical waste management services in the United States. The networks of the Company contain a total of 97 other service facilities, 214 transport sites, and 181 processing facilities.

Stericycle, Inc.is a multi-regional integrated company employing proprietary technology to provide environmentally-responsible management of regulated medical waste for the health care industry. The Company also uses incineration and electro-thermal-deactivation system (NASDAQ:SRCL).